Evidence map›Paper›PMID 40123310›Full record

ArticleAdvanced healthcare materials2025

Human Myobundle Platform for Studying the Role of Notch Signaling in Satellite Cell Phenotype and Function.

Torie Broer, Nick Tsintolas, Stewart Hammond, Abbigail Helfer, Joonbum Lee, Karly Purkey, Sophia DeLuca, Alastair Khodabukus, Nenad Bursac

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Torie BroerDepartment of Biomedical Engineering, Duke University, Durham, NC, 27708, USA.ORCID 0000-0002-6385-6522
Nick TsintolasDepartment of Biomedical Engineering, Duke University, Durham, NC, 27708, USA.
Stewart HammondDepartment of Biomedical Engineering, Duke University, Durham, NC, 27708, USA.
Abbigail HelferDepartment of Biomedical Engineering, Duke University, Durham, NC, 27708, USA.ORCID 0000-0002-8981-5024
Joonbum LeeDepartment of Biomedical Engineering, Duke University, Durham, NC, 27708, USA.
Karly PurkeyDepartment of Biomedical Engineering, Duke University, Durham, NC, 27708, USA.
Sophia DeLucaDepartment of Cell Biology, Duke University, Durham, NC, 27708, USA.ORCID 0000-0001-9432-8186
Alastair KhodabukusDepartment of Biomedical Engineering, Duke University, Durham, NC, 27708, USA.ORCID 0000-0003-2218-7083
Nenad BursacDepartment of Biomedical Engineering, Duke University, Durham, NC, 27708, USA.ORCID 0000-0002-5688-6061

Funding

University Training Program in Biomolecular & Tissue EngineeringT32GM008555 · NIGMS · DUKE UNIVERSITY · PI GERSBACH, CHARLES A. · 1994 to 2021
$8.1M
Vascular, Cardiac, and Lung Alveolar Human Microphysiological Systems for SARS-CoV-2 Drug ScreeningUH3TR002142 · NCATS · DUKE UNIVERSITY · PI TRUSKEY, GEORGE A · 2019 to 2021
$4.0M
Stable therapy in Pompe disease through genome editingR01AR079223 · NIAMS · DUKE UNIVERSITY · PI KOEBERL, DWIGHT D · 2021 to 2025
$3.3M
University Training Program in Biomolecular and Tissue EngineeringT32GM144291 · NIGMS · DUKE UNIVERSITY · PI Charles A. Gersbach, Tatiana Segura · 2022 to 2026
$2.6M
Systemic Inflammation in Microphysiological Models of Muscle and Vascular DiseaseUG3TR002142 · NCATS · DUKE UNIVERSITY · PI TRUSKEY, GEORGE A · 2017 to 2018
$2.1M
Engineering a Human Skeletal Muscle Tissue Model of LGMD2BR01AR082979 · NIAMS · DUKE UNIVERSITY · PI Nenad Bursac · 2023 to 2026
$2.0M
Engineering Heterocellular Human Skeletal Muscle Tissues to Recreate and Study Native Stem Cell Niche FunctionR01AR083155 · NIAMS · DUKE UNIVERSITY · PI Nenad Bursac · 2024 to 2026
$1.5M
Microphysiological Human Tissue Systems for Monitoring of Genome Editing OutcomesU01EB028901 · NIBIB · DUKE UNIVERSITY · PI BURSAC, NENAD, GERSBACH, CHARLES A. · 2019 to 2019
$668k
Engineering Highly Functional Pre-Vascularized Human Skeletal Muscle for In Vitro and In Vivo ApplicationsF31AR080574 · NIAMS · DUKE UNIVERSITY · PI BROER, TORIE M · 2022 to 2023
$80k
NCATS NIH HHS UG3 TR002142NCATS NIH HHS UH3 TR002142NIAMS NIH HHS 1F31AR080574NIAMS NIH HHS F31 AR080574NIAMS NIH HHS R01 AR079223NIAMS NIH HHS R01 AR082979NIAMS NIH HHS R01 AR083155NIBIB NIH HHS U01 EB028901NIGMS NIH HHS T32 GM008555NIGMS NIH HHS T32 GM144291NIH HHS R01AR079223NIH HHS R01AR082979NIH HHS R01AR083155NIH HHS T32GM00855NIH HHS U01EB028901NIH HHS UG3TR002142
6 · The paper itself

Abstract

Notch signaling plays a pivotal role in regulating satellite cell (SC) behavior during skeletal muscle development, homeostasis, and repair. While well-characterized in mouse models, the impact of Notch signaling in human muscle tissues remains largely underexplored. Here, a 3D tissue-engineered model of human skeletal muscle ("myobundles") is utilized as an in vitro platform for temporal control and studies of Notch singaling. Myofiber-specific overexpression of the Notch ligand, DLL1, early in myobundle differentiation increases the abundance of 3D SCs and shifts their phenotype to a more quiescent-like state, along with decreasing muscle mass and function. In contrast, myofiber-specific DLL1 overexpression after one week of myobundle differentiation does not affect 3D SC abundance or muscle function, but increases transcriptomic markers of SC quiescence, confirming the temporal dependence of SC activation and self-renewal on Notch signaling activity. Finally, for the first time these studies show that even after a transient, myofiber-specific upregulation of Notch signaling in myobundles, 3D SCs expanded from these tissues can re-form functional "secondary" myobundles containing an amplified SC pool. Future studies in the described human myobundle platform are expected to aid the development of novel Notch-targeted therapies for muscular dystrophies and aging.

Indexed as

Muscle, SkeletalReceptors, NotchSatellite Cells, Skeletal MuscleSignal TransductionAnimalsCalcium-Binding ProteinsCell DifferentiationHumansMembrane ProteinsMicePhenotypeTissue EngineeringCalcium-Binding ProteinsDLK1 protein, humanMembrane ProteinsReceptors, NotchDLL1muscle stem cellnotch signalingskeletal muscletissue engineering

Identifiers

PMID40123310
PMCPMC12152250

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.